Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules
US10456463B2 · kind B2 · utility
8Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 2011 |
| Grant date | Oct 29, 2019 |
| Priority date | — |
| Expiry date | Apr 21, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described are vaccines having one or more antigens cholesterol and CpG. Aspects of the invention relate to the use of the vaccines of the invention for the treatment and/or prevention of human and animal disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.